{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07455",
      "entity_text" : "PD-1-SHP-1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07424",
      "entity_text" : "PD-1-SHP-2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-1001" ],
      "CellType" : [ "cl:CL:0000084" ]
    }
  },
  "verbose_text" : "Therefore, the CRISPR-Cas9-editable, Jurkat-PD-1-Raji-PD-L1 platform constitutes the most tractable model yet to document via AP-MS and at the T-APC interface how PD-1 coinhibition affects TCR-CD28 signals and to disentangle the respective function of PD-1-SHP-2 and PD-1-SHP-1 complexes.",
  "reading_complete" : "2020-08-08T15:08:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:02:10Z",
  "trigger" : "complexes",
  "evidence" : [ "PD-1-SHP-2 and PD-1-SHP-1 complexes" ],
  "pmc_id" : "6581740",
  "score" : 0
}